This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
“There are a trillion species of microbes, and we only use a couple of them,” said Pluton founder and CTO Barry Goldman, who spent nearly two decades at Monsanto looking into similar ideas. But however useful they are, they’re only a handful out of a near-infinite variety. 3D illustration.
Allozymes was founded by Peyman Salehian (CEO) and Akbar Vahidi (CTO), two Iranian chemical engineers who met while pursuing their PhDs at the National University of Singapore. The reactions occur inside this little drop, which is incubated, tracked, and eventually collected and tested in a fraction of the time a larger sample would take.
For example, I recently talked with the CEO of a biotech investment fund. As a field, biotech has been a leader in applying machine learning (think protein folding); and it’s not clear whether generative AI tools will contribute much to core business of biotech. Stay up on what’s emerging.
Consultants with niche-specific skills will accelerate legal processes and ensure compliance with industry regulations. Company’s CTO Our partnership with Mobilunity-BPO has not only met our expectations but exceeded them. Quality Assurance. We aligned with the client’s requirements and established data quality assurance.
We organize all of the trending information in your field so you don't have to. Join 49,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content